Document is current
Any future updates will be listed below
-
Authors
de Oliveira, Talita H. A. https://orcid.org/0000-0001-8170-0989
Anderson, Lesley A. https://orcid.org/0000-0002-1000-3649
Craig, Stephanie G.
Coleman, Helen G.
Gheit, Tarik
McKay-Chopin, Sandrine
Jamison, Jacqueline
McManus, Damian T.
Cardwell, Christopher R. https://orcid.org/0000-0002-2689-4335
Bingham, Victoria
Johnston, Brian T.
James, Jacqueline A. https://orcid.org/0000-0002-6945-6060
Kunzmann, Andrew T.
-
Funding
Funding for this research was provided by:
Cancer Research UK (C21244/A19029)
- License Information
-
More Information
Article History
Received: 15 February 2024
Revised: 10 March 2025
Accepted: 26 March 2025
First Online: 8 April 2025
Competing interests
: The authors declare no competing interests.
: The Office of Research Ethics Committees Northern Ireland (ORECNI) granted ethical approval for the NIBR (Ref:15/NI/0203) to collect information without consent. Individuals have a right to opt out of registration. Ethical approval for the study of infectious agents and Barrett’s progression was granted under approvals from the ORECNI (Ref:15/NI/0233) and the Northern Ireland Biobank (Ref: NIB15-0146). Further approval for the HPV RNA-ISH analysis was also granted by the Northern Ireland Biobank (Ref: NIB22-0014). The Northern Ireland Biobank has ethical approval from ORECNI (Ref: 21/NI/0019) for the consent, collection, storage, and release of de-identified human tissue samples for research, and this approval extends to the NIB projects referenced above. This study was conducted in accordance with the Declaration of Helsinki.
: The ethical approval from the NIBR allows the use of anonymized patient data for research and publication.
